Improving lung cancer screening in underserved clinics
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
This study is working to make lung cancer screenings easier to access for low-income and underserved communities in Utah, so more people can get the help they need to catch lung cancer early.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11048877 on NIH RePORTER |
What this research studies
This research aims to enhance the implementation of lung cancer screening using Low-Dose Computed Tomography in safety-net clinics that serve low-income and marginalized populations. By partnering with free clinics in Utah, the project will utilize a mixed-methods approach to identify barriers and develop strategies to increase screening rates among eligible patients. The focus is on addressing health inequities related to race, ethnicity, and socioeconomic status, ensuring that more individuals have access to potentially life-saving screenings.
Who could benefit from this research
Good fit: Ideal candidates for this research are uninsured individuals who are at high risk for lung cancer, particularly those from low-income backgrounds and marginalized communities.
Not a fit: Patients who are not eligible for lung cancer screening or those who do not have access to safety-net clinics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase lung cancer screening rates among underserved populations, leading to earlier detection and improved survival outcomes.
How similar studies have performed: Previous research has shown that targeted implementation strategies can effectively increase screening rates in underserved populations, suggesting that this approach has the potential for success.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Estabrooks, Paul — University of Utah
- Study coordinator: Estabrooks, Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.